1.Clinical effect of three-dimensional radiotherapy combined with chemotherapy for esophageal squamous cell carcinoma:a study of 1257 patients
Andu ZHAND ; Jing HAN ; Chun HAN ; Jie KONG ; Lan WANG ; Jun ZHANG ; Kaikai HAO
Chinese Journal of Radiation Oncology 2017;26(5):517-521
Objective To compare the efficacy between three-dimensional radiotherapy (3DRT) combined with chemotherapy and radiotherapy alone for patients with esophageal squamous cell carcinoma.Methods A retrospective analysis was performed for 1257 patients with esophageal squamous cell carcinoma who were admitted to our hospital from July 2003 to June 2012 and met the inclusion criteria;362 patients were treated with 3DRT combined with chemotherapy (chemoradiotherapy group) and 895 patients were treated with radiotherapy alone (radiotherapy group).The short-term outcome, overall survival (OS) rate, and causes of death were analyzed.The Kaplan-Meier method was used to calculate survival rates, and the log-rank test was used for survival difference analysis and univariate prognostic analysis.Results The response rate was 99.1%(346/349) in the chemoradiotherapy group and 99.0%(813/821) in the radiotherapy group (P=0.397).The 1-, 3-, and 5-year OS rates were 74.0%,42.0%,and 32.9% in the chemoradiotherapy group and 65.9%,33.0%,and 23.3% in the radiotherapy group (P=0.000), and were 75.6%,43.5%,and 33.2% in the concurrent chemoradiotherapy group and 65.9%,33.0%,and 23.3% in the radiotherapy group (P=0.000).There were no significant differences in 1-, 3-, and 5-year OS rates between the concurrent chemoradiotherapy group and the sequential chemoradiotherapy group (P=0.583).The sequential chemoradiotherapy group had an insignificant increase in 1-, 3-, and 5-year OS rates compared with the radiotherapy group (P=0.065).Tumor recurrence and local control failure were the main causes of death, followed by distant metastasis.The chemoradiotherapy group had a significantly lower proportion of patients who died of local control failure than the radiotherapy group (7.4% vs.14.7%, P=0.003).Conclusions For patients with esophageal squamous cell carcinoma, chemoradiotherapy leads to significantly improved overall survival compared with radiotherapy alone;compared with radiotherapy alone, sequential chemoradiotherapy results in an increasing trend in OS rates, while concurrent chemoradiotherapy results in significantly increased OS rates.Chemoradiotherapy can reduce the deaths due to local control failure compared with radiotherapy alone.
2.IgM Subclass Antibody 3A6 Inhibits Atherosclerotic Plaque Formation in ApoE-/-Mice
Hui DAI ; Xiaofei SHI ; Kaikai HAO
Journal of Medical Research 2024;53(9):113-116,195
Objective To investigate the effect of the anti-oxidized low density lipoprotein(ox-LDL)IgM subclass antibody 3A6 on the atherosclerotic plaque formation in ApoE-/-mice.Methods The ApoE-/-mice were randomly divided into three groups:control group(intraperitoneal injection of normal saline),5G8group(intraperitoneal injection of nature anti-LDL IgM subclass antibody)and 3A6group(intraperitoneal injection of natural anti-ox-LDL IgM subclass antibody),with 6mice in each group.The body weight of mice and the level of serum lipid in each group were measured after 12 weeks of high-fat and high-cholesterol diet.hematoxylin-eosin staining was used to analyze the pathological changes and plaque area of the aorta in mice.Results There was no significant difference in body weight,serum lipid level and ox-LDL level among the three groups(P=0.087).Compared with the control group,the area of atherosclerotic plaque was significantly decreased in the 3A6group(P=0.023).Conclusion The natural IgM subclass antibody 3A6 can effectively inhibit the formation of atherosclerotic plaque in ApoE-/-mice.
3.Effects of ligustilide regulating RhoA/ROCK signaling pathway on biological behavior of esophageal cancer cells
Kaikai HAO ; Xiaomin WANG ; Zheng LIU ; Dongyang LIU ; Jing LI
Tianjin Medical Journal 2024;52(11):1164-1170
Objective To investigate effects of ligustilide(LIG)on proliferation,apoptosis,angiogenic mimicry and Ras homolog gene family member A(RhoA)/Rho associated coiled coil containing protein kinase 1(ROCK)signaling pathway in esophageal cancer cells.Methods Esophageal cancer cell line EC-109 was treated with LIG at concentrations of 0,12.5,25,50,100,and 200 μmol/L to detect cell activity,and the suitable concentration was selected for subsequent experiments.EC-109 cells were grouped into the control group,the LIG low,medium and high concentration groups(LIG-L,LIG-M and LIG-H groups),and the LIG-H+RhoA activator Naciclassine group(LIG-H+Naciclassine group).Edu was applied to detect cell proliferation,and flow cytometry was applied to detect cell apoptosis.Angiogenetic mimicry was observed.Western blot assay was applied to detect expression levels of proteins related to cell proliferation and apoptosis,and RhoA,ROCK proteins.Nude mouse tumor transplantation experiment was applied to verify the effect of LIG on the growth of esophageal cancer tumors.Immunohistochemistry was applied to detect expression levels of angiogenesis related factors(VEGF),RhoA and ROCK proteins in transplanted tumors.Results Compared with the control group,the vascular mimicry tubular structure of EC-109 cells decreased sequentially in the LIG-L group,the LIG-M group and the LIG-H group.The positive rate of Edu,the expression levels of Cyclin D1,Ki67,Bcl-2,RhoA and ROCK reduced in turn.P21,cell apoptosis rate,the expression of Bax and Caspase-3 increased in sequence(P<0.05).Naciclasine,RhoA activator,partially reversed the effect of LIG on cell proliferation,apoptosis and vasculogenic mimicry of esophageal cancer cells.Nude mouse transplantation tumor experiment showed that compared with the control group,the growth rate of transplanted tumor showed down,tumor volume decreased and the expression levels of RhoA,ROCK and VEGF decreased in the LIG group(P<0.05).Conclusion Ligustilide inhibits the proliferation and angiogenic mimicry of esophageal cancer cells by inhibiting RhoA/ROCK signaling pathway,and promotes the apoptosis of esophageal cancer cells.